A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
NCT00057395 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2005-06-24
Summary
To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.
Conditions
- Esophageal Neoplasms
- Hepatocellular Carcinoma
- Colorectal Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Neoplasms
Interventions
- DRUG
-
Aroplatin (Liposomal NDDP, L-NDDP)
Sponsors & Collaborators
-
Aronex Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
NCT05037149 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
NCT02740985 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
NCT02030067 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors
NCT00424632 ·Status: COMPLETED ·Phase: PHASE1
-
17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00119236 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients
NCT00782574 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
NCT01310179 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors
NCT02235688 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL820 in Adults With Solid Tumors
NCT00129571 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
NCT01359982 ·Status: COMPLETED ·Phase: PHASE1
-
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
NCT00004241 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
NCT00827177 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT05898399 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors
NCT00612703 ·Status: COMPLETED ·Phase: PHASE1
-
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
NCT00454649 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
NCT05084859 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors
NCT00612209 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens
NCT01009190 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
NCT02730481 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
NCT02503423 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
NCT06687070 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of PSB205 in Subjects With Advanced Solid Tumors
NCT03986606 ·Status: UNKNOWN ·Phase: PHASE1
-
SMP-3124LP in Adults With Advanced Solid Tumors
NCT06526819 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06630247 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
NCT03529526 ·Status: UNKNOWN ·Phase: PHASE1